南向资金12月23日持有昭衍新药市值4亿港元,持股比例占37.43%

金融界
24 Dec 2024

12月24日,Choice数据显示,南向资金截至12月23日持有昭衍新药4454.61万股,持股市值4亿港元,较上个交易日增加1041.12万港元,持股数量占发行股的37.43%。

截至23日收盘,昭衍新药当日上涨2.51%,收盘价报8.98港元。

大事提醒

2024年12月23日,公司以每股17.1-17.18人民币回购10万股,回购金额171.4万人民币。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10